Alemtuzumab versus interferon beta-1a in early multiple sclerosis

Dennis Bourdette, Vijayshree Yadav

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Alemtuzumab versus interferon beta-1a in early multiple sclerosis'. Together they form a unique fingerprint.